Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

Search for glaxosmithkline consumer healthcare in registrations and monthly communication reports

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (40)
Results: 1-40 | Export
  1. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Clarissa Schurter, Edelman Global Advisory
    Registration: 1 of 1 (2024-02-15 to present)
    Posted: 2024-02-27
    Subject matter details: 7
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  2. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Alexander MacDonald, Counsel Public Affairs Inc.
    Registration: 1 of 1 (2024-01-29 to present)
    Posted: 2024-02-07
    Subject matter details: 12
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  3. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 19 of 19 (2023-10-09 to present)
    Posted: 2023-10-10
    Subject matter details: 12
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  4. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Registration: 6 of 6 (2023-09-25 to present)
    Posted: 2023-09-29
    Subject matter details: 7
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  5. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Registration: 5 of 6 (2023-09-20 to 2023-09-25)
    Posted: 2023-09-20
    Subject matter details: 6
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  6. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Registration: 4 of 6 (2023-06-09 to 2023-09-20)
    Posted: 2023-06-09
    Subject matter details: 4
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  7. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Registration: 2 of 2 (2023-04-06 to 2023-05-08)
    Posted: 2023-04-11
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  8. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Registration: 1 of 2 (2023-03-29 to 2023-04-06)
    Posted: 2023-03-30
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  9. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Registration: 3 of 6 (2023-03-09 to 2023-06-09)
    Posted: 2023-03-10
    Subject matter details: 3
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  10. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: John Delacourt, Counsel Public Affairs
    Registration: 2 of 2 (2023-01-31 to present)
    Posted: 2023-03-15
    Subject matter details: 15
    Government institutions: 12
    Communication techniques: 3
    Government funding: No
  11. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: John Delacourt, Counsel Public Affairs
    Registration: 1 of 2 (2022-11-25 to 2023-01-31)
    Posted: 2022-12-05
    Subject matter details: 15
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  12. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Registration: 2 of 6 (2022-10-26 to 2023-03-09)
    Posted: 2022-10-26
    Subject matter details: 2
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  13. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Affairs / Ashley M Brambles
    Registration: 1 of 6 (2022-10-24 to 2022-10-26)
    Posted: 2022-10-25
    Subject matter details: 2
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  14. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Pierre Cyr, Edelman Global Advisory
    Registration: 1 of 1 (2022-10-24 to 2024-03-13)
    Posted: 2022-10-28
    Subject matter details: 2
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  15. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 18 of 19 (2022-06-14 to 2023-10-09)
    Posted: 2022-06-15
    Subject matter details: 15
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  16. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Marsha Seca, Edelman Canada / Edelman
    Registration: 1 of 1 (2022-05-10 to 2022-11-16)
    Posted: 2022-06-10
    Subject matter details: 3
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  17. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 12 of 12 (2022-01-18 to 2022-04-22)
    Posted: 2022-01-20
    Subject matter details: 14
    Government institutions: 12
    Communication techniques: 3
    Government funding: No
  18. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: David Murray, Counsel Public Affairs Inc.
    Registration: 4 of 4 (2022-01-18 to 2022-09-23)
    Posted: 2022-01-20
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  19. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ben Parsons, Counsel Public Affairs Inc.
    Registration: 11 of 11 (2022-01-18 to 2022-11-28)
    Posted: 2022-01-20
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  20. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 17 of 19 (2022-01-18 to 2022-06-14)
    Posted: 2022-01-20
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  21. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 11 of 12 (2021-12-01 to 2022-01-18)
    Posted: 2021-12-06
    Subject matter details: 14
    Government institutions: 12
    Communication techniques: 3
    Government funding: No
  22. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ben Parsons, Counsel Public Affairs Inc.
    Registration: 10 of 11 (2021-12-01 to 2022-01-18)
    Posted: 2021-12-06
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  23. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: David Murray, Counsel Public Affairs Inc.
    Registration: 3 of 4 (2021-12-01 to 2022-01-18)
    Posted: 2022-01-14
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  24. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 16 of 19 (2021-12-01 to 2022-01-18)
    Posted: 2022-01-14
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  25. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 10 of 12 (2021-09-22 to 2021-12-01)
    Posted: 2021-09-22
    Subject matter details: 14
    Government institutions: 12
    Communication techniques: 3
    Government funding: No
  26. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 9 of 12 (2021-06-02 to 2021-08-11)
    Posted: 2021-07-15
    Subject matter details: 14
    Government institutions: 12
    Communication techniques: 3
    Government funding: No
  27. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: David Murray, Counsel Public Affairs Inc.
    Registration: 2 of 4 (2021-03-10 to 2021-12-01)
    Posted: 2021-03-15
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  28. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: David Murray, Counsel Public Affairs Inc.
    Registration: 1 of 4 (2021-03-01 to 2021-03-10)
    Posted: 2021-03-04
    Subject matter details: 14
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  29. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ben Parsons, Counsel Public Affairs Inc.
    Registration: 9 of 11 (2021-02-24 to 2021-12-01)
    Posted: 2021-03-15
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  30. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 8 of 12 (2021-02-24 to 2021-06-02)
    Posted: 2021-03-15
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  31. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 15 of 19 (2021-02-24 to 2021-12-01)
    Posted: 2021-03-15
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  32. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 14 of 19 (2021-02-01 to 2021-02-24)
    Posted: 2021-02-03
    Subject matter details: 14
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  33. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ben Parsons, Counsel Public Affairs Inc.
    Registration: 8 of 11 (2021-02-01 to 2021-02-24)
    Posted: 2021-02-03
    Subject matter details: 14
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  34. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 7 of 12 (2021-02-01 to 2021-02-24)
    Posted: 2021-02-03
    Subject matter details: 14
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  35. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Amber Ruddy, Counsel Public Affairs Inc.
    Registration: 4 of 4 (2021-02-01 to 2021-02-03)
    Posted: 2021-02-03
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  36. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 6 of 12 (2020-12-03 to 2021-02-01)
    Posted: 2020-12-23
    Subject matter details: 13
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  37. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 13 of 19 (2020-12-03 to 2021-02-01)
    Posted: 2020-12-23
    Subject matter details: 13
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  38. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ben Parsons, Counsel Public Affairs Inc.
    Registration: 7 of 11 (2020-12-03 to 2021-02-01)
    Posted: 2020-12-23
    Subject matter details: 13
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  39. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Amber Ruddy, Counsel Public Affairs Inc.
    Registration: 3 of 4 (2020-12-03 to 2021-02-01)
    Posted: 2020-12-23
    Subject matter details: 13
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  40. GlaxoSmithKline Consumer Healthcare Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 1 of 1 (2009-01-16 to 2010-06-15)
    Posted: 2009-02-03
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
Monthly communication reports (25)
Results: 1-25 | Export
  1. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-12-12
    Posted: 2024-01-15
    Designated public office holders:
    • Don Davies, Member of Parliament | House of Commons
    Subject matters:
    • Agriculture
    • Health
      •
  2. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-10-04
    Posted: 2023-11-15
    Designated public office holders:
    • Majid Jowhari, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Agriculture
      •
  3. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-10-04
    Posted: 2023-11-15
    Designated public office holders:
    • Todd Doherty, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Agriculture
      •
  4. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-10-04
    Posted: 2023-11-15
    Designated public office holders:
    • Francis Drouin, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Agriculture
      •
  5. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-10-04
    Posted: 2023-11-15
    Designated public office holders:
    • Eshan Naik, Director of Policy, Office of the Leader of the Government in the House of Commons | House of Commons
    • Jean-Sebastien Bock, Deputy Chief of Staff and Director of Policy, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Agriculture
    • Health
      •
  6. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-10-03
    Posted: 2023-11-15
    Designated public office holders:
    • Charles Vincent, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Agriculture
    • Science and Technology
      •
  7. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-10-03
    Posted: 2023-11-15
    Designated public office holders:
    • Shristi Radhakrishnan, Executive Assistant (Chief of Staff) | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Agriculture
    • Science and Technology
      •
  8. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-10-03
    Posted: 2023-11-15
    Designated public office holders:
    • Uttara Chauhan, Director General | Immigration, Refugees and Citizenship Canada (IRCC)
    Subject matters:
    • Health
    • Immigration
      •
  9. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-06-09
    Posted: 2023-07-15
    Designated public office holders:
    • Sandenga Yeba, Senior Policy Advisor, Minister's Office | Health Canada (HC)
    • Jamie Kippen, Chief of Staff, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  10. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-05-30
    Posted: 2023-06-15
    Designated public office holders:
    • rouben Khatchadourian, Vice-President, Strategy | Public Health Agency of Canada (PHAC)
    • Kirsten Goodnough, Director General | Public Health Agency of Canada (PHAC)
    Subject matters:
    • Health
      •
  11. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-05-29
    Posted: 2023-06-15
    Designated public office holders:
    • sandenga Yeba, Policy Advisor | Health Canada (HC)
    Subject matters:
    • Health
      •
  12. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-04-28
    Posted: 2023-05-15
    Designated public office holders:
    • Adam Van Koeverden, Parliamentary Secretary, Health Canada | House of Commons
    Subject matters:
    • Health
    • Agriculture
      •
  13. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-03-09
    Posted: 2023-04-15
    Designated public office holders:
    • Jamie Kippen, Chief of Staff, Minister's Office | Health Canada (HC)
    • Francis Drouin, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Agriculture
      •
  14. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-03-09
    Posted: 2023-04-15
    Designated public office holders:
    • Rouben Khatchadourian, Vice President, Strategic Support | Public Health Agency of Canada (PHAC)
    • Rodrigo Arancibia, Director for Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Agriculture
    • Science and Technology
      •
  15. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-03-09
    Posted: 2023-04-15
    Designated public office holders:
    • sandenga Yeba, Policy Advisor | Health Canada (HC)
    Subject matters:
    • Agriculture
    • Health
    • Science and Technology
      •
  16. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-01-10
    Posted: 2023-02-15
    Designated public office holders:
    • Guillaume Bertrand , Communications | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor, Minister's Office | Health Canada (HC)
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)
    • Victor Kandasamy, Policy Advisor (Quebec) | Health Canada (HC)
    Subject matters:
    • Health
      •
  17. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2022-12-16
    Posted: 2023-01-16
    Designated public office holders:
    • Victor Kandasamy, Policy Advisor (Quebec), Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  18. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2022-12-14
    Posted: 2023-01-16
    Designated public office holders:
    • Paul Hershaw, Director of Operations, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  19. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2022-11-23
    Posted: 2022-12-15
    Designated public office holders:
    • Jamie Kippen, Chief of Staff, Minister's Office | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  20. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2022-11-18
    Posted: 2022-12-15
    Designated public office holders:
    • Sandenga Yeba, Senior Policy Advisor, Minister's Office | Health Canada (HC)
    • Jamie Kippen, Chief of Staff to the Minister, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  21. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Pierre Cyr, Edelman Global Advisory
    Occurred: 2022-11-02
    Posted: 2022-12-15
    Designated public office holders:
    • Jamie Kippen, Chief of Staff, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  22. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Affairs / Ashley M Brambles
    Occurred: 2022-10-24
    Posted: 2022-11-15
    Designated public office holders:
    • Jamie Kippen, Chief of Staff, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
    • Agriculture
      •
  23. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Pierre Cyr, Edelman Global Advisory
    Occurred: 2022-10-24
    Posted: 2022-11-15
    Designated public office holders:
    • Jamie Kippen, Chief of Staff, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  24. GlaxoSmithKline Consumer Healthcare Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Occurred: 2009-07-02
    Posted: 2009-08-17
    Designated public office holders:
    • Tim Vail, Director of Communications, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  25. GlaxoSmithKline Consumer Healthcare Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Occurred: 2009-01-16
    Posted: 2009-02-16
    Designated public office holders:
    • Meena Ballantyne, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
Date Modified: